export const newsData = [

    {
        title: "OSSTEC Close 2.5M funding round",
        date: new Date(202,5 1),
        type: 'update',
        tags: ["Awards", "Innovation"],
        description: "A strong start to 2025 saw OSSTEC close their investment round to fund regulatory approval and market launch, as well as growing the team to 9 people!",
        // image: "/images/news/awards.jpeg",
    },
    {
        title: "Succesful Cadaver Lab in HSS, New York",
        date: new Date(2024, 11),
        type: 'update',
        tags: ["Awards", "Innovation"],
        description: "2024 closed with a succesful cadaver lab held in HSS, New York. The world renowned team of surgeons on the OSSTEC clinical advisory board provided valuable feedback to perfect the OSSTEC implants and surgical instruments.",
        // image: "/images/news/awards.jpeg",
    },
    {
        title: "Our incredible journey in 2023",
        date: new Date(2024, 0),
        type: 'update',
        tags: ["Awards", "Innovation"],
        description: "As 2024 kicks off, we're taking a moment to reflect on an incredible journey in 2023. We closed our oversubscribed investment round totalling £2M, grew our team to 8 people, unveiled our first product to the world and expanded reach in our target markets including trips to ISTA (New York), AAHKS (Dallas) and AAOS (Las Vegas). We are incredibly excited for a huge 2024!",
        // image: "/images/news/awards.jpeg",
        link: "https://www.linkedin.com/feed/update/urn:li:activity:7152244929858052096/"
    },

    {
        title: "OSSTEC Exhibit at ISTA, New York",
        date: new Date(2023, 9),
        type: 'update',
        tags: ["Awards", "Innovation"],
        description: "OSSTEC had an amazing time exhibiting at International Society for Technology in Arthroplasty (ISTA), New York, in September. It was a pleasure to unveil our first product to surgeons and industry. Some key highlights include podium presentations from our team demonstrating research at OSSTEC and surgical usability sessions trialling our devices.",
        // image: "/images/news/awards.jpeg",
        link: "https://www.linkedin.com/posts/osstec_cementless-fixation-patient-activity-7118312197675462657-ZWAc?utm_source=share&utm_medium=member_desktop"
    },
    {
        title: "OSSTEC: Recognized for Excellence in Technological Innovation",
        date: new Date(2023, 5),
        type: 'update',
        tags: ["Awards", "Innovation"],
        description: "OSSTEC is honored to announce nominations for three prestigious awards by the UK Business Angels Association and EISA. Our gratitude extends to the Royal Academy of Engineering and Innovate UK for their sponsorship. These nominations underscore our team's dedication to technological innovation.",
        // image: "/images/news/awards.jpeg",
        link: "https://www.linkedin.com/posts/osstec_awards-startup-investment-activity-7074394214410706945-v8yQ?utm_source=share&utm_medium=member_desktop"
    },
    {
        title: "OSSTEC and CEO Dr. Munford: Nominated and Awaiting Acclaim",
        date: new Date(2023, 5),
        type: 'update',
        tags: ["Awards", "Innovation"],
        description: "OSSTEC is nominated for Best SEIS Investee Company 2023, showcasing our medtech innovation prowess. CEO, Dr. Maxwell Munford, is up for Entrepreneur of the Year. Gratitude to our team and partners; awaiting results with anticipation.",
        // image: "/images/news/eisa_awards.jpeg",
        link: "https://www.linkedin.com/posts/osstec_medtech-entrepreneur-seis-activity-7072197140910895105-MKQ6?utm_source=share&utm_medium=member_desktop"
    },
    {
        title: "OSSTEC's £1.2M Funding Milestone: Paving the Way for MedTech Advancements",
        date: new Date(2023, 3),
        type: 'news',
        tags: ["Funding", "Innovation"],
        description: "OSSTEC successfully closes an oversubscribed £1.2M funding round, bolstering our journey from lab to operating room with our 3D printing and biomimetic implants. This boost empowers team growth and tech development. Immense gratitude to our investors and supporters, including SFC, Parkwalk Advisors, and Embryo Ventures. More updates soon.",
        // image: "/images/news/funding.jpeg",
        link: "https://www.linkedin.com/posts/osstec_osstec-innovation-deeptech-activity-7047191762292875265-I7b5?utm_source=share&utm_medium=member_desktop"
    }
]